Ad5-CMV-Cre: expresses the Cre recombinase protein. Non BCM Academic

The Commonwealth of Virginia, through the University of Virginia as the contracting organization, awarded contract A207_PO-0473411 to Baylor College of Medicine on August 26, 2026. This procurement involves the delivery of a specialized biological research reagent: one vial of Ad5-CMV-Cre, an adenoviral vector expressing the Cre recombinase protein for academic research purposes. The unit price for this single vial is $144, resulting in a cumulative contract value of $144. The deliverable is designated for Jennifer Kashatus.

This contract represents a straightforward purchase of a non-commercial academic research material from an established medical research institution. The scope of work is limited to the procurement and delivery of the specified biological reagent, with no additional services indicated in the contract documentation. Given the nature of the delivery item and the contracting organization, performance is anticipated to occur at the University of Virginia or associated research facilities in Virginia.